AG
LRMR icon

Artal Group’s Larimar Therapeutics LRMR Stock Holding History

Artal Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-58,333
Closed -$1.92M – 113
2019
Q1 		$1.92M Hold
58,333
– – 0.08% 96
2018
Q4 		$3.46M Sell
58,333
-8,334
-13% -$823K 0.13% 78
2018
Q3 		$9.35M Sell
66,667
-33,333
-33% -$4.05M 0.24% 57
2018
Q2 		$12.3M Hold
100,000
– – 0.26% 41
2018
Q1 		$8.94M Buy
100,000
+16,667
+20% +$1.41M 0.11% 50
2017
Q4 		$4.62M Hold
83,333
– – 0.07% 74
2017
Q3 		$3.52M Hold
83,333
– – 0.06% 76
2017
Q2 		$3.51M Hold
83,333
– – 0.06% 76
2017
Q1 		$4.66M Buy
83,333
+41,666
+100% +$2.07M 0.1% 62
2016
Q4 		$1.59M Buy
+41,667
New +$1.69M 0.04% 82

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return